Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 8x8 Inc (EGHT) vs Novartis AG (NVS) Price & Performance

Novartis AGTrade

Price performance (Past 24H)

Key statistics

8x8 Inc vs Novartis AG — how do they compare? 8x8 Inc trades at $2.13 (market cap $309.09M), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 955.6× 8x8 Inc's market cap, and Novartis AG pays a 3.07% dividend while 8x8 Inc pays none. Which is the better fit depends on your goals.

EGHTNVS
Market Cap
$309.09M$295.37B
Sector
TechnologyHealth
52-Week High
$2.76$168.62
52-Week Low
$1.59$119.31
Enterprise Value
$576.02M$336.69B
Dividend Yield
3.07%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About 8x8 Inc

8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.

Read more on EGHT

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS